Skip to main content
SBC
NASDAQ Industrial Applications And Services

CEO Sells Additional Shares from Underwriters' Option in Public Offering

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
7
Price
$3.3
Mkt Cap
$338.504M
52W Low
$2.974
52W High
$5.75
Market data snapshot near publication time

summarizeSummary

SBC Medical Group Holdings Inc.'s Chairman and CEO, Yoshiyuki Aikawa, sold an additional $1.4 million in common stock, representing the exercise of the underwriters' option from a previously announced public offering.


check_boxKey Events

  • CEO Sells Additional Shares

    Chairman and CEO Yoshiyuki Aikawa sold 465,000 shares of common stock for $1,405,462.50 at a price of $3.0225 per share on April 28, 2026.

  • Related to Prior Offering

    This sale represents the exercise of the underwriters' option to purchase additional shares in connection with the underwritten public offering that initially closed on April 21, 2026.


auto_awesomeAnalysis

This Form 4 reports an additional sale of 465,000 shares by Chairman and CEO Yoshiyuki Aikawa, totaling $1.4 million. This transaction is part of the underwriters' option to purchase additional shares related to the underwritten public offering that initially closed on April 21, 2026, which was previously disclosed in a 424B7 and 13D/A filing. While this sale is a continuation of a prior event, it represents a further reduction in the CEO's direct holdings and adds to the recent pattern of insider distribution. Investors should note the ongoing sales by the CEO following the recent public offering.

At the time of this filing, SBC was trading at $3.30 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $338.5M. The 52-week trading range was $2.97 to $5.75. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed SBC - Latest Insights

SBC
Apr 30, 2026, 5:21 PM EDT
Filing Type: 10-K/A
Importance Score:
9
SBC
Apr 29, 2026, 9:38 PM EDT
Filing Type: 4
Importance Score:
7
SBC
Apr 21, 2026, 9:07 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
SBC
Apr 20, 2026, 4:27 PM EDT
Filing Type: 424B7
Importance Score:
9
SBC
Mar 27, 2026, 7:31 AM EDT
Filing Type: 10-K
Importance Score:
8
SBC
Mar 27, 2026, 6:50 AM EDT
Filing Type: 8-K
Importance Score:
8
SBC
Mar 27, 2026, 6:40 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
SBC
Mar 10, 2026, 9:54 PM EDT
Filing Type: 4
Importance Score:
8
SBC
Mar 10, 2026, 9:53 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
SBC
Jan 05, 2026, 7:01 AM EST
Filing Type: 8-K
Importance Score:
7